As a result, receptor dimerization, autophosphorylation, and activation of signaling pathways may not occur.18 Anti-EGFR antibodies for targeted boron delivery to cancer cells have been described in combination with boron-containing dendrimers,19 Fc-binding peptide-dodecaborate,20 boron phosphate nanoparticles21, and others. The gene discussed is EGFR; the disease is cancer.